← Back

Latvia ZVA (State Agency of Medicines) · Latvia · 7 Jan 2026 · Rule change

Requirement for cover letters in Type IA variations abolished

Original title: Prasība par pavadvēstuļu iesniegšanu IA tipa izmaiņām ir atcelta

AI-generated summary

The Coordination Group for Mutual Recognition and Decentralised Procedures (CMDh) has decided to abolish the requirement to submit cover letters for Type IA variations effective 1 July 2026. Seven guidance documents on variations, renewals, eCTD use, and MRP procedures will be updated accordingly. The updated documents will be published on the CMDh website under Procedural Guidance, Templates, and Questions and Answers sections.

Dates and deadlines
Applies from
1 Jul 2026
From Latvia ZVA (State Agency of Medicines)

Savstarpējās atzīšanas un decentralizētās procedūras koordinācijas grupa (CMDh) ir pieņēmusi lēmumu no 2026. gada 1. jūlija atcelt prasību iesniegt pavadvēstules IA tipa izmaiņām.

Līdz ar to tiks atjaunināti šādi vadlīniju dokumenti:

- Requirements on submissions for variations and renewals within MRP and national procedures

- BPG on the use of eCTD in the MRP/DCP

- Cover letter for variation applications in MRP

- Questions and answers on variations

- BPG for the allocation of the MRP variation number for Type I notifications, Type II variations, grouping and worksharing (Chapter 1)

- BPG for the processing of Type IA minor variations (notifications) in MRP (Chapter 3)

- BPG for the processing of grouped applications in MRP (Chapter 6)

Atjauninātie dokumenti tiks publicēti CMDh tīmekļvietnē sadaļās “Procedural Guidance > Variations”, “Procedural Guidance > eSubmissions”, kā arī “Templates > Variations” un “Questions and Answers”.

Excerpt from the official page. The original is authoritative.